Kyungpook National university hospital
Daegu, South Korea
NCT Number: NCT07618845
A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults
Trial opening soon.
Get Notified19 year–64 year
All sexes
Interventional
Phase 1
Daegu, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
AD-230 1Tab., Per Oral, Fasted
AD-230 1 Tab., Per Oral, Fed state
Time frame: -24hours to 72hours
Time frame: -24hours to 72hours
Contact information is provided by the study sponsor or research team.
Addpharma Inc.
Industry
A Randomized, Open-label, 2-period, 2-sequence, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of AD-230 in Healthy Adult Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07571876
Chronic Liver Disease (CLD), Digestive System Diseases
View Trial DetailsNCT07521241
Chronic Liver Disease (CLD)
Seoul, South Korea
View Trial DetailsNCT07502196
Cardiac Abnormalities, Chronic Liver Disease (CLD)
View Trial DetailsNCT07670611
Avitaminosis, Bile Duct Diseases
Bangkok, Thailand
View Trial Details